Methods and systems for presenting an inhalation experience

• US 8,738,395 B2
• Filed: 04/21/2009
• Issued: 05/27/2014
• Est. Priority Date: 12/30/2008
• Status: Active Grant

• Current Assignee: The Invention Science Fund I, L.L.C. (Intellectual Ventures LLC)
• Original Assignee: The Invention Science Fund I, L.L.C. (Intellectual Ventures LLC)
• Inventors: Hyde, Roderick A., Langer, Robert, Leuthardt, Eric C., Lord, Robert W., Sweeney, Elizabeth A., Tegreene, Clarence T., Wood, Lowell L. Jr.
• Primary Examiner(s): NGUYEN, HIEP VAN
• Application Number:
  US12/386,669
• Publication Number:
  US 20100163028A1
• Time in Patent Office: 1,862 Days
• Field of Search: 705/2
• US Class Current: 705/2
• CPC Class Codes: A61B 5/01 Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue clinical contact thermometers G01K13/20
• CPC Class Codes: A61B 5/02 Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
• CPC Class Codes: A61B 5/024 Detecting, measuring or recording pulse rate or heart rate A61B5/0205, A61B5/021 take precedence
• CPC Class Codes: A61B 5/11 Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb for measuring pulse A61B5/02 ;A61B5/1038 takes precedence; motion detection to correct for motion artifacts in physiological signals A61B5/721
• CPC Class Codes: A61B 5/145 Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissuemeasuring of blood pressure or blood flow A61B5/02; non-radiation detecting or locating of foreign bodies in blood A61B5/06
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/165 Evaluating the state of mind, e.g. depression, anxiety
• CPC Class Codes: A61B 5/377 using evoked responses
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61B 5/4833 Assessment of subject's compliance to treatment
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61B 5/486 Bio-feedback A61B5/375 takes precedence
• CPC Class Codes: A61B 5/6822 Neck
• CPC Class Codes: A61M 11/00 Sprayers or atomisers specially adapted for therapeutic purposes in general B05B; aerosol containers B65D83/14
• CPC Class Codes: A61M 15/00 Inhalators drug delivery in endotracheal tubes A61M16/04
• CPC Class Codes: A61M 15/0028 using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
• CPC Class Codes: A61M 15/0065 Inhalators with dosage or measuring devices A61M15/0028 takes precedence; dosage devices incorporated in aerosol cans B65D83/52
• CPC Class Codes: A61M 15/009 using medicine packages with incorporated spraying means, e.g. aerosol cans pocket atomiser of the injector type A61M11/08
• CPC Class Codes: A61M 15/02 with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
• CPC Class Codes: A61M 15/08 Inhaling devices inserted into the nose
• CPC Class Codes: A61M 2021/0016 : by the smell sense
• CPC Class Codes: A61M 2205/3553 : remote, e.g. between patient's home and doctor's office
• CPC Class Codes: A61M 2205/3569 : sublocal, e.g. between console and disposable
• CPC Class Codes: A61M 2205/3584 : using modem, internet or bluetooth
• CPC Class Codes: A61M 2205/3592 : using telemetric means, e.g. radio or optical transmission
• CPC Class Codes: A61M 2205/50 : with microprocessors or computers
• CPC Class Codes: A61M 2205/581 : by audible feedback
• CPC Class Codes: A61M 2205/582 : by tactile feedback
• CPC Class Codes: A61M 2205/583 : by visual feedback
• CPC Class Codes: A61M 2205/588 : by olfactory feedback, i.e. smell
• CPC Class Codes: A61M 2209/088 : on the body
• CPC Class Codes: A61M 2230/201 : Glucose concentration
• CPC Class Codes: A61M 2230/205 : partial oxygen pressure (P-O2)
• CPC Class Codes: A63F 2300/65 : for computing the condition of a game character
• CPC Class Codes: A63F 2300/6692 : using special effects, generally involving post-processing, e.g. blooming
• CPC Class Codes: G16H 20/13 : delivered from dispensers
• CPC Class Codes: G16H 40/67 : for remote operation

Abstract

Methods, computer program products, and systems are described that include monitoring at least one health attribute of an individual during an artificial sensory experience, associating a characteristic of the artificial sensory experience with the at least one health attribute of the individual, and modifying at least one of an inhalation device-dispensed bioactive agent or the artificial sensory experience at least partially based on associating a characteristic of the artificial sensory experience with the at least one health attribute of the individual.

Claims

1. A system, comprising:

a monitorer module configured to monitor at least one health attribute of an individual during at least one virtual reality experience;

an associater module configured to associate a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual; and

a modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual,

wherein at least one of the monitorer module, the associater module or the modifier module is at least partially implemented using hardware.

2. The system of claim 1, wherein the monitorer module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a data receiver module configured to receive data from an automated medical device.

3. The system of claim 1, wherein the monitorer module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a health attribute monitorer module configured to monitor at least one of physical activity, body weight, body mass index number, heart rate, blood oxygen level, or blood pressure temporally associated with the at least one virtual reality experience.

4. The system of claim 1, wherein the monitorer module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a neurophysiological monitorer module configured to monitor a neurophysiological activity.

5. The system of claim 4, wherein the neurophysiological monitorer module configured to monitor a neurophysiological activity comprises:

a neurophysiological measurer module configured to measure at least one physiologic activity using at least one of electroencephalography, computed axial tomography, positron emission tomography, magnetic resonance imaging, functional magnetic resonance imaging, functional near-infrared imaging, or magnetoencephalography.

6. The system of claim 1, wherein the monitorer module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a recorder module configured to record at least one monitored health attribute of the individual.

7. The system of claim 1, wherein the monitorer module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

an observer module configured to observe at least one indication of an expected behavior pattern proximate in time to a characteristic of the at least one virtual reality experience.

8. The system of claim 1, wherein the associater module configured to associate a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a physiological response associater module configured to associate a characteristic of the at least one virtual reality experience with at least one physiological response of the individual.

9. The system of claim 8, wherein the physiological response associater module configured to associate a characteristic of the at least one virtual reality experience with at least one physiological response of the individual comprises:

an artificial sensory experience associater module configured to associate at least one of an object, an action, an avatar, or an environment of the at least one virtual reality experience with at least one physiological response of the individual.

10. The system of claim 8, wherein the physiological response associater module configured to associate a characteristic of the at least one virtual reality experience with at least one physiological response of the individual comprises:

a health attribute associater module configured to associate a characteristic of the at least one virtual reality experience with at least one of blood pressure, pulse, pupil dilation, respiration rate, skin response, or voice response of the individual.

11. The system of claim 1, wherein the associater module configured to associate a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a report accepter module configured to accept a report from the individual of an association of a characteristic of the at least one virtual reality experience and the at least one health attribute.

12. The system of claim 1, wherein the associater module configured to associate a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a utilizer module configured to utilize an algorithm configured to correlate at least one virtual reality characteristic with at least one health attribute.

13. The system of claim 1, wherein the associater module configured to associate a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a comparer module configured to compare current measured behavior with expected behavior data that is correlated with the at least one virtual reality experience.

14. The system of claim 1, wherein the modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

an access modifier module configured to modify access to at least a portion of the at least one virtual reality experience.

15. The system of claim 14, wherein the access modifier module configured to modify access to at least a portion of the at least one virtual reality experience comprises:

a restricter module configured to restrict access to at least a portion of the at least one virtual reality experience.

16. The system of claim 14, wherein the access modifier module configured to modify access to at least a portion of the virtual world comprises:

a granter module configured to grant access to at least a portion of the at least one virtual reality experience.

17. The system of claim 1, wherein the modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a visual object modifier module configured to modify visible content in the at least one virtual reality experience to alter at least one effect of the bioactive agent.

18. The system of claim 17, wherein the visual object modifier module configured to modify visible content in at least one virtual reality experience to alter at least one effect of the bioactive agent comprises:

a color scheme modifier module configured to modify a color scheme of the at least one virtual reality experience to alter at least one effect of the bioactive agent.

19. The system of claim 17, wherein the visual object modifier module configured to modify visible content in at least one virtual reality experience to alter at least one effect of the bioactive agent comprises:

a text modifier module configured to modify at least a portion of text of the at least one virtual reality experience to alter at least one effect of the bioactive agent.

20. The system of claim 1, wherein the modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a sound alterer module configured to alter audible content in the at least one virtual reality experience.

21. The system of claim 20, wherein the sound alterer module configured to alter audible content in at least one virtual reality experience comprises:

a music alterer module configured to alter at least a portion of music in the at least one virtual reality experience.

22. The system of claim 20, wherein the sound alterer module configured to alter audible content in at least one virtual reality experience comprises:

an ambient noise alterer module configured to alter at least a portion of ambient noise in the at least one virtual reality experience.

23. The system of claim 20, wherein the sound alterer module configured to alter audible content in at least one virtual reality experience comprises:

a voice alterer module configured to alter at least a portion of voice in the at least one virtual reality experience.

24. The system of claim 1, wherein the modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

an efficacy modifier module configured to modify the at least one virtual reality experience to alter the efficacy of the bioactive agent.

25. The system of claim 1, wherein the modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a side effect modifier module configured to modify the at least one virtual reality experience to alter a side effect of the bioactive agent.

26. The system of claim 1, wherein the modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

an adder module configured to add at least one of visual or audio content to the at least one virtual reality experience.

27. The system of claim 1, wherein the modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a deleter module configured to delete at least one of visual or audio content from the at least one virtual reality experience.

28. The system of claim 1, wherein the modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a sensate modifier module configured to modify a sensate experience.

29. The system of claim 28, wherein the sensate modifier module configured to modify a sensate experience comprises:

a stimulus modifier module configured to modify at least one of an olfactory stimulus, a haptic stimulus, a visual stimulus, an auditory stimulus, or a taste stimulus.

30. The system of claim 1, wherein the modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a mobile device modifier module configured to modify at least one virtual reality experience implemented on a mobile device.

31. The system of claim 1, wherein the modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a dosage modifier module configured to modify a bioactive agent dosage.

32. The system of claim 1, wherein the modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a bioactive agent modifier module configured to modify at least one bioactive agent in a bioactive agent combination.

33. The system of claim 1, wherein the modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprises:

a delivery modifier module configured to modify a bioactive agent delivery method.

34. The system of claim 1, wherein the monitorer module configured to monitor at least one health attribute of an individual during at least one virtual reality experience comprises:

a monitorer module configured to monitor at least one attribute related to a central nervous system of an individual during the at least one virtual reality experience.

35. The system of claim 1, wherein the monitorer module configured to monitor at least one health attribute of an individual during at least one virtual reality experience, the associater module configured to associate a characteristic of the at least one virtual reality experience with at the at least one health attribute of the individual, and the modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprise:

a monitorer module configured to monitor at least one health attribute of an individual during an artificial sensory experience;

an associater module configured to associate a characteristic of the artificial sensory experience with the at least one health attribute of the individual; and

a modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the artificial sensory experience at least partially based on associating a characteristic of the artificial sensory experience with the at least one health attribute of the individual.

36. The system of claim 1, wherein the monitorer module configured to monitor at least one health attribute of an individual during at least one virtual reality experience, the associater module configured to associate a characteristic of the at least one virtual reality experience with at the at least one health attribute of the individual, and the modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual comprise:

a monitorer module configured to monitor at least one attribute related to a central nervous system of an individual during an artificial sensory experience;

an associater module configured to associate a characteristic of the artificial sensory experience with the at least one attribute related to a central nervous system of the individual; and

a modifier module configured to modify at least one of an inhalation device-dispensed bioactive agent or at least a portion of the artificial sensory experience at least partially based on associating a characteristic of the artificial sensory experience with the at least one attribute related to a central nervous system of the individual.

37. The system of claim 1, wherein the monitorer module configured to monitor at least one health attribute of an individual during at least one virtual reality experience comprises:

a monitorer module configured to monitor at least one health attribute of an individual during at least one of an artificial sensory experience, a virtual world, a massively multiplayer online game, a learning tutorial, a computer-based simulated environment, a text-based chat room, a picture chat, an instant messaging application, an online class, an internet marketplace, a computer conferencing, an online game, a single player game, a networked game, a video game, an interactive experience including at least a religious ceremony, an interactive experience including at least a combat training exercise, a screen recording, a written document, an audio file, a virtual scent environment, an interactive experience including at least a secular ceremony, a social networking environment, an online learning environment, an online educational experience, an online shopping environment, or an online medical information environment.

38. A computer program product, comprising:

at least one non-transitory computer readable medium including at least;

one or more instructions for monitoring at least one health attribute of an individual during at least one virtual reality experience;

one or more instructions for associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual; and

one or more instructions for modifying at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual.

39. A system, comprising:

circuitry for monitoring at least one health attribute of an individual during at least one virtual reality experience;

circuitry for associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual; and

circuitry for modifying at least one of an inhalation device-dispensed bioactive agent or at least a portion of the at least one virtual reality experience at least partially based on associating a characteristic of the at least one virtual reality experience with the at least one health attribute of the individual.